Puma Biotechnology, Inc.
DistributorUnclaimedPuma Biotechnology, Inc.
What to check
- Exists and is operating nowRegistration and company ID are valid, status is active, it files its reports, accounts are not frozen, the site answers, and its age matches what it claims. · Website live (Jul 2026)proof
- Independently confirmedCertificates found in official registries, an active legal entity ID (LEI), fulfilled public contracts, real filed financials. · Listed in a source registry
- 5 more checks are not yet possible from open public sources for suppliers in United States.
Independent signals from open data. Open items are not confirmed, ask on contact.
Protect Your Money Before You Pay+
Safe Bets (You can get a refund)
- Credit cards
- PayPal (specifically "Goods and Services")
- Escrow services (where your money is held safely until the goods actually arrive)
- Letter of Credit (best for large, bulk orders)
Red Flags (Your money is gone for good)
- Wire transfers to personal bank accounts
- Crypto
- Western Union or MoneyGram
- Gift cards
The ultimate warning sign: If a supplier refuses cards or escrow and only pushes for non-reversible payment methods, walk away immediately. This is the number one sign of a scam. Either insist on escrow or drop the deal.
Double-check the names: The name on the bank account must perfectly match the officially registered company name. If it doesn't, stop right there.
First-time orders: Always use an independent escrow service for your first order. This ensures the supplier only gets paid after you have the goods in hand.
About
Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in-licensed the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous), and PB357 in 2011. In 2022, Puma in-licensed global research and development and commercial rights to alisertib, a selective, small molecule, orally administered inhibitor of aurora kinase A. Neratinib is a potent irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2 and HER4. Puma has been focused on developing the oral version of neratinib, and its most advanced drug candidates are directed at the treatment of HER2-positive breast ca
- Categories
- Primary markets
Distribution capabilities
- Partner roles
- Countries covered
- Deal preferences
- Not specified
Company facts
Where is Puma Biotechnology, Inc. based?
Puma Biotechnology, Inc. is based in United States.
Is Puma Biotechnology, Inc. a manufacturer or a distributor?
Puma Biotechnology, Inc. is a distributor listed on Hell of a Partner.
Is Puma Biotechnology, Inc. verified on Hell of a Partner?
Not yet. Puma Biotechnology, Inc. is listed from public sources and has not completed verification. Review the trust signals on this page before you make contact.